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ABSTRACT
Introduction Delirium is a dangerous syndrome of acute 
brain dysfunction that is common in the emergency 
department (ED), especially among the geriatric 
population. Most systematic reviews of interventions 
for delirium prevention and treatment have focused on 
inpatient settings. Best practices of effective delirium care 
in ED settings have not been established. The primary 
objective of this study is to identify pharmacologic and 
non- pharmacologic interventions as applied by physicians, 
nursing staff, pharmacists and other ED personnel to 
prevent incident delirium and to shorten the severity and 
duration of prevalent delirium in a geriatric population 
within the ED.
Methods and analysis Searches using subject headings 
and keywords will be conducted from database inception 
through June 2020 in MEDLINE, EMBASE, Web of Science, 
PsychINFO, CINAHL, ProQuest Dissertations and Theses 
Global and Cochrane CENTRAL as well as grey literature. 
Database searches will not be limited by date or language. 
Two reviewers will identify studies describing any 
interventions for delirium prevention and/or treatment in 
the ED. Disagreements will be settled by a third reviewer. 
Pooled data analysis will be performed where possible 
using Review Manager. Risk ratios and weighted difference 
of means will be used for incidence of delirium and other 
binary outcomes related to delirium, delirium severity or 
duration of symptoms, along with 95% CIs. Heterogeneity 
will be measured by calculating I2, and a forest plot 
will be created. If significant heterogeneity is identified, 
metaregression is planned using OpenMeta to identify 
possible sources of heterogeneity.
Ethics and dissemination This is a systematic review 
of previously conducted research; accordingly, it does 
not constitute human subjects research needing ethics 
review. This review will be prepared as a manuscript and 
submitted for publication to a peer- reviewed journal, and 
the results will be presented at conferences.
PROSPERO trial registration number CRD42020169654.
INTRODUCTION
Delirium is an acute confusional state char-
acterised by declines in attention, awareness 
and cognition. Fluctuations of mental status 
over time are characteristic and necessary 
for diagnosis.1 2 Delirium is common in the 
acute care setting including the emergency 
department (ED), and is particularly prev-
alent among adults older than 65 years. 
As many as 7%–17% of older adults who 
present to the ED meet diagnostic criteria 
for delirium.3–9 ED providers miss delirium 
in up to 80% of cases.6 ED delirium is asso-
ciated with significantly increased in- hospital, 
30- day and 6- month mortality, as well as loss 
of independence,5 9–11 accelerated cognitive 
decline and post- traumatic stress disorder 
which are especially troubling to patients and 
their families.11 12 Delirium can be character-
ised by motor subtypes—namely hypoactive 
(92%), hyperactive or mixed delirium (8%).4 
Our understanding of delirium prognosis is 
evolving through a growing body of literature 
exploring associations between classification 
of delirium aetiology, motor subtypes and 
severities of outcomes.4 13 14
Interventions aimed at reducing the inci-
dence and severity of delirium have been 
studied in various settings, but our prelim-
inary searches revealed a paucity of ED 
research.15 Multicomponent prevention 
programmes in hospitalised patients showed 
a reduction in delirium incidence.16 17 Several 
Cochrane reviews have been published 
since 2012, which reported the utility 
Strengths and limitations of this study
 ► This study will utilise three reviewers to analyse ar-
ticles and resolve discrepancies of data collection.
 ► Study will be conducted with a well- defined search 
strategy including a search of unpublished and grey 
literature.
 ► Study will search a broad group of databases to 
identify studies produced by physicians, nurses, 
pharmacists and other researchers.
 ► There will be increased heterogeneity due to the 
large number of interventions included.
 ► Some outcomes, such as delirium duration, may 
be assessed differently in each study, limiting the 
analysis.
M
edicine Library &
. P
rotected by copyright.
 on N
ovem
ber 16, 2020 at W
ashington U
niversity S
chool of
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2020-037915 on 6 O
ctober 2020. D
ow
nloaded from
 
2 Dahlstrom EB, et al. BMJ Open 2020;10:e037915. doi:10.1136/bmjopen-2020-037915
Open access 
of pharmacological agents,18 19 delirium prevention 
programmes in hospital setting16 and long- term care.20 
Thus, both pharmacologic and non- pharmacologic 
interventions applied by physicians, nursing staff, phar-
macists and other ED personnel could have a role in 
reducing the incidence, severity or duration of delirium 
in the ED, as reported in the studies from other practice 
settings including inpatient medical, surgical and palli-
ative care units and long- term care facilities.16–19 21–24 
The ED is a critical setting for delirium screening and 
preventative measures, since more than half of geriatric 
hospitalisations begin in the ED.25
Clearly identifying, preventing and treating delirium is 
critical for improved patient care. Recognising the impor-
tance of improved delirium evaluation, management and 
prevention, the American College of Emergency Physi-
cians developed an electronic tool, the ADEPT tool, to 
help improve care provided of older adults with or at risk 
of delirium in the ED.26 ADEPT stands for Assess, Diag-
nose, Evaluate, Prevent, and Treat, and is used as a check-
list to aid in the care of the confused and agitated elderly 
patient. The purpose of this study is to better under-
stand which delirium prevention or treatment strategies 
provide the most compelling evidence of effectiveness 
and feasibility in ED settings.
Objective of systematic review and meta-analysis
This review aims to identify pharmacologic and non- 
pharmacologic interventions as applied by physicians, 
nursing staff, pharmacists and other ED personnel to 
prevent incident delirium and to shorten the severity and 
duration of prevalent delirium in a geriatric population 
within the ED.
METHODS AND ANALYSIS
Protocol design and registration
The study is a systematic review and meta- analysis to 
summarise randomised controlled trials and quasi- 
experimental studies. The study protocol adheres to the 
Preferred Reporting Items for Systematic Reviews and 
Meta- analysis Protocols (PRISMA- P; see online supple-
mental table 1).27
Study characteristics
This review will consider quasi- experimental or 
randomised controlled trial designs that evaluate the 
effectiveness of a prevention or treatment intervention(s) 
for all forms of delirium (ie, hypoactive, hyperactive and 
mixed subtypes), evaluating incidence and severity of 
delirium as primary outcomes. This review will exclude 
studies solely focused on delirium tremens or emer-
gence delirium, but will not exclude studies that include 
these diagnoses as part of a broader delirium definition. 
Published studies, studies that are pending publication, 
and unpublished studies will be included to reduce the 
bias of selective outcome reporting. Further inclusion 
and exclusion criteria are listed in table 1.
Types of participants
This systematic review will include studies where partici-
pants are aged 65 or older who present initially to the ED 
and are evaluated for delirium. We will include studies 
that use subjects under the age of 65 if they also report 
data on people over age 65.
Types of interventions
Interventions of interest are those aimed at prevention or 
treatment of delirium. Prevention will be defined as any 
Table 1 Eligibility criteria
PICOS 
strategy Inclusion criteria Exclusion criteria
Population Age 65 or older, initial presentation to the ED None
Intervention Multicomponent interventions, single component non- pharmacologic 
interventions performed by physicians, nursing staff and pharmacists, 
pharmacologic interventions performed by physicians, nursing staff and 
pharmacists
None
Comparator Usual care None
Outcomes Primary outcomes: Absence of the use of 
validated delirium assessment 
tool for delirium diagnosis or 
severity
Incidence of delirium (prevention study)
Severity of delirium (treatment study)
Secondary outcomes (treatment study):
Delirium duration
In- hospital and long- term mortality, discharge to skilled nursing facility, long- 
term quality of life, functional status and long- term cognition
Study design Randomised controlled trials, quasi- experimental studies None
ADEPT, Assess, Diagnose, Evaluate, Prevent, Treat; DSM, Diagnostic and Statistical Manual of Mental Disorders; GRADE, Grades of 
Recommendation Assessment, Development and Evaluation; ICD, International Classification of DIsease; PICOS, Population, Intervention, 
Comparison, Output, Study.
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method employed specifically to reduce the incidence 
of delirium. Treatment will be defined as any treatments 
aiming to reduce the severity or duration of diagnosed 
delirium. Both single- component and multicomponent 
non- pharmacologic interventions will be considered for 
this systematic review. All pharmacologic interventions 
such as typical and atypical antipsychotics, benzodiaze-
pines, alpha-2 agonists, sedatives, opioids, cholinesterase 
inhibitors, melatonin and melatonin receptor agonists 
will be considered for inclusion. Single- component and 
multicomponent non- pharmacologic interventions as 
well as pharmacologic interventions will be included if 
performed by a physician, nurse, pharmacist or other ED 
staff.
Types of outcome measures
For all outcome measures, delirium should be defined 
and assessed in triage, ED or inpatient by a validated or 
acceptable diagnostic tool for delirium reported in the 
peer- reviewed journal, including Single Question to Iden-
tify Delirium, Ultrabrief two- item Bedside Test, Delirium 
Triage Screen, 4AT, brief Confusion Assessment Method, 
applicable diagnostic tools listed on the Delirium Severity 
Measures Summary Table developed by the Network for 
Investigation of Deliurium: Unifying Scientists (NIDUS), 
ICD 10 criteria and DSM IV/V diagnosis.28 29 Delirium 
severity will be measured initially in triage or the ED using 
any of the existing tools defined in the Delirium Severity 
Measures Summary Table developed by NIDUS, or as 
defined in the specific study.29 The primary outcomes will 
be incidence of delirium for any prevention study and 
severity of delirium for any treatment study.
Secondary outcomes for any treatment study will 
include delirium duration. Duration will be defined 
using each study’s respective definition of duration, and 
or measured as first instance of multiple consecutive posi-
tive tests until time of first instance of multiple consecu-
tive negative tests for studies that include such data. We 
will also include all- cause mortality, in- hospital mortality, 
level of care, discharge to skilled care facility, any type of 
fall, quality of life and long- term cognitive impairment. 
In- hospital mortality will be defined as any death while 
in the ED or during the initial admission. Level of care 
will be defined categorically as discharge to home, admis-
sion to a step- down unit, or admission to an intensive care 
unit. Discharge to a skilled care facility will be assessed 
as new placement in a skilled nursing home immediately 
following the initial ED visit and primary hospital admis-
sion, but not including home health nursing. Long- term 
quality of life, functional status, and long- term cognition 
will be included as a secondary outcome if assessed using 
a validated, non- disease specific tool (such as the Activi-
ties of Daily Living Questionnaire).
Types of studies
Both randomised controlled trials and quasi- experimental 
studies will be included.
Timing
We will use timing parameters that extend throughout 
the hospital stay and up to a 180- day follow- up.
Setting
This review will be restricted to studies where initial 
delirium assessment starts in the ED or in triage and 
subsequent intervention(s) starts in triage, the ED or 
inpatient wards. This is because more than 50% of older 
adults who required hospitalisation are admitted through 
the ED, and effective screening, treatment and delirium 
prevention programme can have a significant impact on 
the remainder of their hospital stay.25
Information sources
Strategies for searching the literature will be developed 
to locate studies relating to the concepts; delirium, ED, 
interventions and the geriatric population. The strategies 
will use subject headings and keywords. A librarian (HH) 
will conduct searches in MEDLINE (Ovid), EMBASE 
(Elsevier), Web of Science, PsycINFO (EBSCOhost), 
CINAHL, ProQuest Dissertations and Theses Global and 
Cochrane CENTRAL (Wiley). The search strategies will 
not be limited by language. Each database will be searched 
from database inception through June 2020. The team 
will supplement the electronic database searches by 
looking for trial protocols and ongoing studies through 
ClinicalTrials. gov and PROSPERO. Additional unpub-
lished sources and conference abstracts will be sought 
out directly from conference proceedings and primary 
authors. For each included article, the reference list will 
be searched for additional relevant studies.
Search strategy
The specific search strategies for each database will be 
developed by a health sciences librarian (HH) trained 
in systematic review searching. The team will provide 
input on the terminology for the strategies, and the strat-
egies will be peer reviewed, using the PRESS guideline, 
by another health sciences librarian.30 A draft PubMed 
search strategy follows in online supplemental file.
 Clinicaltrials. gov and PROSPERO will be searched for 
incomplete or recently completed studies. As the paucity 
of literature exists in the prevention and intervention of 
delirium in the ED, we will identify any preliminary or 
unpublished study through the content experts (JHH, 
MK, GA and JL).
Data management
Database search results will be transferred to EndNote 
and deduplicated using the published methodology 
for deduplication as laid out by Bramer, Giustini and 
de Jonge.31 Citations will be stored and sorted using 
Endnote. Data will be compiled and meta- analysed using 
Review Manager (RevMan, V.5.3; The Nordic Cochrane 
Centre, The Cochrane Collaboration). OpenMeta 
(Analyst) (Center for Evidence- Based Medicine, Brown 
School of Public Health) will be used for regression with 
continuous covariates.
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Selection process
This review will follow the PRISMA standards for reporting 
a systematic review and meta- analysis.27 Studies identified 
via the search strategy and other methods will undergo 
an initial review by two independent reviewers who will 
review the title and abstract to determine whether the 
study meets the defined inclusion criteria. Studies where 
there is disagreement between the reviewers will be 
included in the secondary review.
Selected studies will subsequently be subjected to full- 
text review, again with two independent reviewers util-
ising inclusion and exclusion criteria. A third reviewer will 
settle disagreements. We will report the kappa to measure 
inter- rater reliability. This analysis will be documented in 
a PRISMA flow diagram, and the process will result in a 
final list of included articles.
Data collection
Reviewers will use a standardised data collection form 
to gather desired information (see online supplemental 
table 2). The form will be developed following the 
style outlined by ‘Data collection form for intervention 
review—RCTs and non- RCTs’ from the Cochrane Collab-
oration.32 Data collection will be done independently. 
Calibration exercises will be used prior to conducting the 
review to ensure that each reviewer is consistent with their 
data collection. A third reviewer will check for discrepan-
cies between data sheets for each given article and settle 
any disagreements. We will reach out to original study 
authors for details or data if any uncertainties arise.
Data items
We will collect data on the year of publication, study 
design, method of evaluating for delirium or delirium 
severity, and interventions for delirium prevention and/
or treatment. We will extract data on outcomes, including 
incidence of delirium, duration of delirium, delirium 
severity, mortality (30- day and in- hospital), new admission 
to a skilled nursing facility after ED visit, admission to an 
intensive care unit, quality of life and persistent cognitive 
deficits for intervention and control groups.
Risk of bias assessment
The study will use the Cochrane risk of bias assessment 
tool for randomised clinical trials and New- Castle- Ottawa 
scale for quasi- experimental studies for quality assess-
ments.33–35 Direct quotes from each study will be used for 
all subsections of the tool in order to assess the risk of bias. 
Two independent reviewers will assess risk of bias, and the 
third reviewer will settle any discrepancy. We will report 
kappa to report the inter- rater agreement. The quality of 
evidence for an association between treatment, preven-
tion and delirium- related outcomes will be evaluated in 
accordance with the GRADE system.36 This system grades 
quality of evidence at four levels: high (4), moderate (3), 
low (2) and very low (1). For high evidence, the require-
ments are a randomised, double- blinded study design 
with no selection biases. We will assess publication bias 
using funnel plots.
Data synthesis
If the studies, or an adequate subset of the studies in the 
review have sufficiently homogeneous outcomes data, 
meta- analysis will be conducted. Data associated with 
primary and secondary outcomes will be analysed in 
aggregate. For dichotomous data, risk ratios will be calcu-
lated with 95% CIs. A weighted difference of means will 
be used for continuous data with 95% CIs. Heterogeneity 
will be assessed using demographic features (age, sex) as 
well as study design factors (such as treatment type), and 
an I2 value will be calculated. A value of less than 50% will 
be considered sufficiently homogeneous.37 Forest plots 
will be created using this data. Individual outcomes will 
be combined and calculated using RevMan V.5.3.38
Subgroup analysis
Subgroup analysis will be conducted based on type of 
intervention (pharmacologic and non- pharmacologic), 
delirium motor subtype (hyperactive, hypoactive, mixed), 
delirium severity, presumed delirium aetiology (phenotype) 
and whether incident or prevalent delirium was studied. 
Possible sources of heterogeneity tested includes age, anti-
psychotics, delirium subtype and study year. A linear meta- 
regression model weighted to reflect the variance of the 
individual studies will be used to model the data.
Patient and public involvement
Patients and the public were not directly involved in the 
development of the research question or the design of the 
study, however many of the outcome measures (including 
quality of life, level of care and functional status) were 
chosen specifically to study the impact of delirium preven-
tion and treatment measures on the patient experience. 
This study was conducted without direct patient involve-
ment and patients were not involved in patient recruit-
ment or conduction of the study.
Amendments
Amendments to this protocol, particularly database 
searches, will be documented in PROSPERO.
ETHICS AND DISSEMINATION
There will be no human subject participants involved in 
this review. The results of this review will be submitted 
for publication to a peer- reviewed journal. Other dissem-
ination may include presentations at conferences and 
seminars.
DISCUSSION
Delirium is common and serious geriatric syndrome for 
which prevention and treatment best practices have not 
been established in the ED setting.39 One of the strengths 
of this study is that it will compile the relevant evidence 
for delirium prevention and intervention within the ED 
setting to identify any effective strategy. Another strength 
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of this study is that it will be conducted using a well- 
defined search strategy. We will consult transdisciplinary 
delirium for grey literature, unpublished works and 
ongoing studies to minimise the risk of bias of selective 
outcome reporting.
The review will explore a new insight to prevention 
and treatment options to employ in the ED, which have 
become the main entrance for the majority of older 
adults to the hospital. The clinical care delivered in 
the ED influences downstream clinical care and there-
fore, may have a significant impact on outcomes. We 
are aware of a total of seven Cochrane reviews published 
since 2012 that examine the various delirium prevention 
and treatment interventions in varied clinical settings 
(table 2).16 18–20 40–42
One Cochrane review examined the effect of antipsy-
chotic agents for delirium treatment in non- ICU hospi-
talised patients and found no impact on delirium severity 
or duration.40 Due to limited research in the palliative 
care setting, evidence was deemed insufficient to assess 
the impact of pharmacologic therapies for the treatment 
of delirium in terminally ill patients.18 Similarly, the 
data were deemed insufficient to evaluate the effect of 
cholinesterase inhibitors in the treatment of delirium in 
the non- ICU hospital setting. A review evaluating preven-
tion strategies in long- term care settings found limited 
evidence on interventions for preventing delirium, but 
a software- based intervention to identify high- risk medi-
cations and a pharmacist- led medication review reduced 
the incidence of delirium.20 There is strong evidence 
that a multicomponent delirium prevention programme 
reduces the incidence of delirium in the non- ICU 
hospital setting. Despite the ample number of systematic 
reviews, it is important to note that none of these focused 
on delirium interventions in the ED (table 2).
Our study protocol may have limitations, including 
increased heterogeneity due to the large number of 
different interventions being included. There may also 
be limitations to the statistical power of our findings 
depending on the quantity of literature in this setting. 
Although we set a comprehensive list of outcomes, it 
may not be possible to find any studies that list them, for 
example, quality of life.
The importance of delirium prevention and manage-
ment in the ED setting is underscored by the inclusion of 
delirium recognition and management as a best practice 
in the Geriatric ED Guidelines,43 a quality indicator for 
geriatric emergency care,44 a core competency for emer-
gency medicine residents45 as well as by the recent dissem-
ination of the ADEPT tool.26 Although guidelines and 
core competencies reflect the expert consensus- based 
best practices in EM, high- quality research evidence 
to support ED delirium prevention and intervention 
approaches have been lacking. This review will address 
a critical need to synthesise research into delirium 
prevention and management in the ED setting to further 
improve the care of older ED patients with or at risk for 
delirium and create a roadmap for future researchers.46 47
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Table 2 A list of Cochrane reviews examining delirium 
intervention since 2012
Study author/year Main intervention Setting*
Woodhouse et al 
(2019)20
Software- based 
identification of high- risk 
medication
Long- term care
Burry et al (2018)40 Antipsychotic agent Non- ICU inpatient 
ward
Herling et al 
(2018)41
Delirium prevention study 
(pharmacological)
ICU
Yu et al (2018)19 Cholinesterase inhibitor Non- ICU inpatient 
ward
Punjasawadwong 
et al (2018)42
Electroencephalogram Perioperative
Siddiqi et al (2016)16 Delirium prevention study 
(pharmacological and non- 
pharmacological treatment)
Mixed setting 
(none ED)
Candy et al (2012)18 Pharmacological therapy Delirium with 
AIDS in the 
palliative care
*We were unable to identify any review in the ED.
ED, emergency department; ICU, intensive care unit.
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